Each article is made available under the terms of the . ​All of our articles are available to download individually in PDF format.


 

How I Manage Myelofibrosis

How I Manage Myelofibrosis

August 31, 2017 at 8:29 AM 0 comments

*Anca Lupu President of the Romanian Society of Hematology; Vice President of the Romanian Society Haemostasis and Thrombosis; Head of Hematology Department, Colțea Clinical Hospital; Professor of Hematology, University of Medicine and Pharmacy ‘Carol Davila’, Bucharest, Romania *Correspondence to cercetarecoltea@yahoo.com Disclosure: The author has declared no conflicts of interest. Received:Read More

How I Diagnose Hypereosinophilic Syndromes

How I Diagnose Hypereosinophilic Syndromes

August 31, 2017 at 8:28 AM 0 comments

*Simon Kavanagh, Jeffrey H. Lipton Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada *Correspondence to simon.kavanagh@uhn.ca Disclosure: The authors have declared no conflicts of interest. Received: 21.02.17 Accepted: 07.08.17 Citation: EMJ. 2017;2[3]:15-20. Abstract Hypereosinophilic syndromes are a group of disorders characterised byRead More

Management of Multiply Relapsed Aggressive Non-Hodgkin Lymphoma: New Perspectives

Management of Multiply Relapsed Aggressive Non-Hodgkin Lymphoma: New Perspectives

August 31, 2017 at 8:27 AM 0 comments

This symposium took place on 13th June 2017, as a part of the 14th International Conference on Malignant Lymphoma (ICML) in Lugano, Switzerland Chairpersons: Eric Van Den Neste,1 Ruth Pettengell2 Speakers: Pier Luigi Zinzani,3 Eric van Den Neste,1 Ruth Pettengell,2 Amjad Hayat,4 Kai Hübel5 1. Department of Haematology, Cliniques Universitaires,Read More

Redefining Later-Line Therapy in Metastatic Colorectal Cancer

Redefining Later-Line Therapy in Metastatic Colorectal Cancer

August 31, 2017 at 8:26 AM 0 comments

This symposium took place on 29th June 2017 as part of the 19th World Congress on Gastrointestinal Cancer in Barcelona, Spain Chairpersons: Andres Cervantes,1 Dirk Arnold2 Speakers: Marc Peeters,3 Julien Taieb4 1. CIBERONC. Department of Medical Oncology, Biomedical Research Institute, Incliva, University of Valencia, Valencia, Spain 2. Instituto CUF deRead More

Management of B-Cell Lymphoma: Where Are We Now and Where Are We Going?

Management of B-Cell Lymphoma: Where Are We Now and Where Are We Going?

August 31, 2017 at 8:25 AM 0 comments

This symposium took place on 15th June 2017, as part of the 14th International Conference on Malignant Lymphoma (ICML) in Lugano, Switzerland Chairperson: Gilles Salles1 Speakers: Nathan H. Fowler,2 Umberto Vitolo3 1. Haematology Department, Lyon-Sud University Hospital Complex, Pierre-Bénite, France 2. Department of Lymphoma and Myeloma, University of Texas MDRead More

Editor’s Pick: Renal Involvement in Multiple Myeloma

Editor’s Pick: Renal Involvement in Multiple Myeloma

August 31, 2017 at 8:24 AM 0 comments

Fifteen years ago, renal involvement and renal failure were almost inevitable consequences of multiple myeloma, dramatically impacting survival and quality of life. Since the introduction of innovative drugs (the so called ‘new drugs’ and ‘newer drugs’), autologous haemopoietic cell transplantations, and the innovative technique of light chain removal, myeloma outcomesRead More

Treatment Options in Cardiogenic Shock with Intra-Aortic Balloon Counterpulsation

Treatment Options in Cardiogenic Shock with Intra-Aortic Balloon Counterpulsation

August 31, 2017 at 8:23 AM 0 comments

*Markus W. Ferrari Clinic of Internal Medicine I, HELIOS Dr-Horst-Schmidt-Clinic, Wiesbaden, Germany *Correspondence to markus.ferrari@helios-kliniken.de Disclosure: The author has declared no conflicts of interest. Acknowledgements: Writing assistance was provided by Julia Bates, PhD, of Oxford Science Manuscripts. Support: Financial support for the article was provided by Getinge. Received: 04.05.17 Accepted:Read More

Peyronie’s Disease: Recent Treatment Modalities

Peyronie’s Disease: Recent Treatment Modalities

August 31, 2017 at 8:22 AM 0 comments

Ali Can Albaz, *Oktay Üçer Department of Urology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey *Correspondence to uceroktay@yahoo.com Disclosure: The authors have declared no conflicts of interest. Received: 17.01.17 Accepted: 26.04.17 Citation: EMJ. 2017;2[3]:63-70. Abstract Peyronie’s disease (PD), which is characterised by fibrous plaque formation in the tunica albugineaRead More

Significance of Asymptomatic Bacteriuria

Significance of Asymptomatic Bacteriuria

August 31, 2017 at 8:21 AM 0 comments

*Jharna Mandal Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India *Correspondence to drjharna@gmail.com Disclosure: The author has declared no conflicts of interest. Received: 30.12.16 Accepted: 15.06.17 Citation: EMJ. 2017;2[3]:71-77. Abstract Since the recognition of asymptomatic bacteriuria (ABU), several studies have questioned its significance. It isRead More

The Role of Selective Serotonin Reuptake Inhibitors in Premature Ejaculation

The Role of Selective Serotonin Reuptake Inhibitors in Premature Ejaculation

August 31, 2017 at 8:20 AM 0 comments

*Alka Aggarwal,1 *Sunder Lal Jethani,1 RK Rohatgi,1 Juhi Kalra2 1. Department of Anatomy, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India 2. Department of Pharmacology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India *Correspondence to alkadr2011@rediffmail.com or sljethani2107@gmail.com Disclosure: The authors have declared noRead More